Showing results (311-320 of 357) with videos related to
Sort By:
Pageof 36
The Journal of Infectious Diseases|November 20, 2020
Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral TherapyShane D Falcinelli, Kayla W Kilpatrick, Jenna Read, et al.Journal of Virology|December 21, 2022
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment ControlAdam Wedrychowski, Holly Anne Martin, Yijia Li, et al.Journal of Virology|October 16, 2023
HIVepsilon-seq-scalable characterization of intact persistent proviral HIV reservoirs in womenKirston Barton, James M Ferguson, Ira W Deveson, et al.Journal of Virology|August 21, 2020
SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus MacaquesAmir Dashti, Chevaughn Waller, Maud Mavigner, et al.Antimicrobial Agents and Chemotherapy|October 24, 2023
A truncated HIV Tat demonstrates potent and specific latency reversal activityEllen Van Gulck, Marion Pardons, Erik Nijs, et al.JCI Insight|August 18, 2017
HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversalGuoxin Wu, Michael Swanson, Aarthi Talla, et al.Plos Medicine|August 17, 2010
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trialRajesh T Gandhi, Lu Zheng, Ronald J Bosch, et al.The Journal of Clinical Investigation|December 23, 2025
Single cell characterization of the gastrointestinal HIV reservoir reveals heterogeneous cellular phenotypesJackson J Peterson, Shipra Chandel, Katherine James, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapyRajesh T Gandhi, Robert W Coombs, Ellen S Chan, et al.AIDS (London, England)|August 11, 2020
Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infectionCynthia L Gay, Dayna T Neo, Aaron S Devanathan, et al.Pageof 36